cyclazosin has been researched along with prazosin in 12 studies
Studies (cyclazosin) | Trials (cyclazosin) | Recent Studies (post-2010) (cyclazosin) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
---|---|---|---|---|---|
22 | 0 | 4 | 7,914 | 713 | 682 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Crucianelli, M; Giardinà, D; Leonardi, A; Melchiorre, C; Poggesi, E; Romanelli, R | 1 |
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Budriesi, R; Chiarini, A; Leonardi, A; Melchiorre, C; Minarini, A | 1 |
Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
Giardinà, D; Gulini, U; Massi, M; Melchiorre, C; Piloni, MG; Pompei, P; Rafaiani, G | 1 |
Crucianelli, M; Giardinà, D; Melchiorre, C; Taddei, C; Testa, R | 1 |
Angeli, P; Giardinà, D; Gulini, U; Leonardi, A; Marucci, G; Melchiorre, C; Poggesi, E; Polimanti, O; Sagratini, G | 1 |
Angeli, P; Buccioni, M; Giardinà, D; Gulini, U; Leonardi, A; Marucci, G; Melchiorre, C; Poggesi, E; Sagratini, G | 1 |
Bexis, S; Docherty, JR | 1 |
Imanishi, A; Latifpour, J; Ueda, S; Yamamoto, Y; Yono, M; Yoshida, M | 1 |
Abdelkarim, H; Albee, LJ; Gao, X; Gaponenko, V; Majetschak, M; Volkman, BF | 1 |
Alsufyani, HA; Docherty, JR; McCormick, PA | 1 |
1 review(s) available for cyclazosin and prazosin
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
11 other study(ies) available for cyclazosin and prazosin
Article | Year |
---|---|
Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Binding Sites; Cattle; Cerebral Cortex; CHO Cells; COS Cells; Cricetinae; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Quinazolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Stereoisomerism | 1996 |
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Binding, Competitive; Drug Design; Humans; In Vitro Techniques; Male; Quinazolines; Quinoxalines; Rats; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Spleen; Structure-Activity Relationship; Vas Deferens | 1998 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Structure-activity relationships in prazosin-related compounds. 2. Role of the piperazine ring on alpha-blocking activity.
Topics: Adrenergic alpha-Antagonists; Animals; Hemodynamics; Male; Piperazines; Prazosin; Quinazolines; Quinoxalines; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship | 1993 |
Receptor binding profile of cyclazosin, a new alpha 1B-adrenoceptor antagonist.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Male; Prazosin; Quinazolines; Quinoxalines; Rats; Receptors, Adrenergic, alpha-1 | 1995 |
Searching for cyclazosin analogues as alpha(1B)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Binding Sites; CHO Cells; Clone Cells; Cricetinae; Guinea Pigs; Humans; Male; Prazosin; Quinazolines; Quinoxalines; Rats; Receptors, Adrenergic, alpha-1; Spleen; Vas Deferens | 2003 |
Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Binding, Competitive; Furans; Male; Molecular Structure; Prazosin; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Spleen; Stereoisomerism; Structure-Activity Relationship; Vas Deferens | 2007 |
Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Body Temperature; Fever; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Prazosin; Quinazolines; Quinoxalines; Receptors, Adrenergic, alpha-1; Thymine | 2008 |
Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Hypertension; Male; Naphthalenes; Nitric Oxide Synthase; Pelvis; Penis; Piperazines; Prazosin; Prostate; Quinazolines; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Regional Blood Flow; Urinary Bladder | 2008 |
Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Topics: Adrenergic alpha-1 Receptor Antagonists; beta-Arrestins; Binding Sites; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Humans; MAP Kinase Signaling System; Myocytes, Smooth Muscle; Nuclear Magnetic Resonance, Biomolecular; Prazosin; Quinazolines; Quinoxalines; Receptors, CXCR; Receptors, CXCR4 | 2018 |
Both α
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Male; Muscle Contraction; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Spleen; Thymine; Yohimbine | 2021 |